Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Monteagudo Ortiz

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
RSC Medicinal Chemistry|August 30, 2021
Using membrane perturbing small molecules to target chronic persistent infectionsCassandra L Schrank, Ingrid K Wilt, Carlos Monteagudo Ortiz, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2022
nTZDpa (non-thiazolidinedione PPARγ partial agonist) derivatives retain antimicrobial activity without improving renal toxicityMadeline M Dekarske, Lewis Oscar Felix, Carlos Monteagudo Ortiz, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
RSC Medicinal Chemistry|August 30, 2021
Using membrane perturbing small molecules to target chronic persistent infectionsCassandra L Schrank, Ingrid K Wilt, Carlos Monteagudo Ortiz, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2022
nTZDpa (non-thiazolidinedione PPARγ partial agonist) derivatives retain antimicrobial activity without improving renal toxicityMadeline M Dekarske, Lewis Oscar Felix, Carlos Monteagudo Ortiz, et al.
Pageof 1